DOSE · Rapid Dose Therapeutics Corp. · Financials
Market Cap
14.47M CAD
Shares
137.78M
Volume · Nov 6
8000
Avg daily vol (3M)
30.54K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.
Revenue
2.77M
+33%
FY2026
Net Income
3.39M
-37.3%
FY2026
Gross Margin
49.15%
-7.4pp
FY2026
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2026 | FY2025 |
|---|---|---|
| CAD | 2.77M | 2.09M |
| CAD | 1.36M | 1.18M |
| CAD | 3.39M | 5.4M |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
Debt Profile
No verified debt profile is available yet. This does not establish that the company has no debt or covenants.